28/11/2022
Published by Fondazione Gianni Bonadonna at 28/11/2022
Categories

Abemaciclib and pembrolizumab in HR+/HER2- metastatic breast cancer

Do you like it?0
Read more
21/11/2022
Published by Fondazione Gianni Bonadonna at 21/11/2022
Categories

How to select patients with breast and ovarian cancer for the treatment with olaparib

Do you like it?0
Read more
14/11/2022
Published by Fondazione Gianni Bonadonna at 14/11/2022
Categories

Talazoparib as monotherapy in advanced breast cancer

Do you like it?0
Read more
09/11/2022
Published by Fondazione Gianni Bonadonna at 09/11/2022
Categories

Olaparib shows promising results in early breast cancer

Do you like it?0
Read more
31/10/2022
Published by Fondazione Gianni Bonadonna at 31/10/2022
Categories

Trastuzumab deruxtecan in HER2+ breast cancer with brain metastases

Do you like it?0
Read more
24/10/2022
Published by Fondazione Gianni Bonadonna at 24/10/2022
Categories

Clinical benefits of an early therapeutic targeting of ESR1 mutation

Do you like it?0
Read more
17/10/2022
Published by Fondazione Gianni Bonadonna at 17/10/2022
Categories

Treatment selection with genomics for metastatic breast cancer

Do you like it?0
Read more
10/10/2022
Published by Fondazione Gianni Bonadonna at 10/10/2022
Categories

Pembrolizumab as post-nephrectomy adjuvant therapy in renal cell carcinoma

Do you like it?0
Read more
03/10/2022
Published by Fondazione Gianni Bonadonna at 03/10/2022
Categories

Neoadjuvant immunotherapy as a promising approach in melanoma and colon cancer

Do you like it?0
Read more
123456789
Next page